Monday, December 23, 2024
HomeTagsANeuroTech

ANeuroTech

ANeuroTech receives positive feedback from the FDA for its pivotal Phase IIIb development programme for ANT-01 as an adjunctive anti-depression drug for Major Depressive...

ANeuroTech, a leader in the development of innovative mental health treatments with minimal or no side effects, announces that following a successful pre-IND meeting,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics